nodes	percent_of_prediction	percent_of_DWPC	metapath
Silodosin—ABCB1—esophageal cancer	0.787	1	CbGaD
Silodosin—Swelling face—Capecitabine—esophageal cancer	0.000561	0.053	CcSEcCtD
Silodosin—Rhinorrhoea—Cisplatin—esophageal cancer	0.000447	0.0423	CcSEcCtD
Silodosin—Rhinorrhoea—Capecitabine—esophageal cancer	0.000329	0.0312	CcSEcCtD
Silodosin—Nasal congestion—Cisplatin—esophageal cancer	0.000289	0.0273	CcSEcCtD
Silodosin—Orthostatic hypotension—Cisplatin—esophageal cancer	0.00024	0.0227	CcSEcCtD
Silodosin—Breast disorder—Cisplatin—esophageal cancer	0.000238	0.0225	CcSEcCtD
Silodosin—Nasopharyngitis—Cisplatin—esophageal cancer	0.000235	0.0222	CcSEcCtD
Silodosin—Hepatic function abnormal—Capecitabine—esophageal cancer	0.000222	0.021	CcSEcCtD
Silodosin—Vascular purpura—Capecitabine—esophageal cancer	0.000217	0.0205	CcSEcCtD
Silodosin—Libido decreased—Capecitabine—esophageal cancer	0.000209	0.0198	CcSEcCtD
Silodosin—Purpura—Capecitabine—esophageal cancer	0.000201	0.019	CcSEcCtD
Silodosin—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.000192	0.0182	CcSEcCtD
Silodosin—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000192	0.0181	CcSEcCtD
Silodosin—Liver function test abnormal—Capecitabine—esophageal cancer	0.000179	0.0169	CcSEcCtD
Silodosin—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000177	0.0167	CcSEcCtD
Silodosin—Breast disorder—Capecitabine—esophageal cancer	0.000175	0.0166	CcSEcCtD
Silodosin—Nasopharyngitis—Capecitabine—esophageal cancer	0.000173	0.0164	CcSEcCtD
Silodosin—Cardiac disorder—Cisplatin—esophageal cancer	0.000169	0.016	CcSEcCtD
Silodosin—Immune system disorder—Cisplatin—esophageal cancer	0.000164	0.0155	CcSEcCtD
Silodosin—Mediastinal disorder—Cisplatin—esophageal cancer	0.000164	0.0155	CcSEcCtD
Silodosin—Jaundice—Capecitabine—esophageal cancer	0.000146	0.0138	CcSEcCtD
Silodosin—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000141	0.0134	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000134	0.0127	CcSEcCtD
Silodosin—Liver function test abnormal—Methotrexate—esophageal cancer	0.000133	0.0126	CcSEcCtD
Silodosin—Breast disorder—Methotrexate—esophageal cancer	0.00013	0.0123	CcSEcCtD
Silodosin—Nervous system disorder—Cisplatin—esophageal cancer	0.000127	0.012	CcSEcCtD
Silodosin—Tachycardia—Cisplatin—esophageal cancer	0.000126	0.0119	CcSEcCtD
Silodosin—Skin disorder—Cisplatin—esophageal cancer	0.000125	0.0119	CcSEcCtD
Silodosin—Cardiac disorder—Capecitabine—esophageal cancer	0.000124	0.0118	CcSEcCtD
Silodosin—Angiopathy—Capecitabine—esophageal cancer	0.000122	0.0115	CcSEcCtD
Silodosin—Immune system disorder—Capecitabine—esophageal cancer	0.000121	0.0115	CcSEcCtD
Silodosin—Mediastinal disorder—Capecitabine—esophageal cancer	0.000121	0.0114	CcSEcCtD
Silodosin—Hypotension—Cisplatin—esophageal cancer	0.000121	0.0114	CcSEcCtD
Silodosin—Mental disorder—Capecitabine—esophageal cancer	0.000117	0.0111	CcSEcCtD
Silodosin—Erectile dysfunction—Methotrexate—esophageal cancer	0.000115	0.0109	CcSEcCtD
Silodosin—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000112	0.000554	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—ALDH2—esophageal cancer	0.000112	0.000552	CbGpPWpGaD
Silodosin—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000112	0.0105	CcSEcCtD
Silodosin—ABCB4—Metabolism—PTGS2—esophageal cancer	0.000111	0.000546	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—GNG7—esophageal cancer	0.00011	0.000544	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CSNK1A1—esophageal cancer	0.00011	0.000542	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—ANXA1—esophageal cancer	0.000109	0.000537	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—GNG7—esophageal cancer	0.000108	0.000532	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—CXCL2—esophageal cancer	0.000107	0.000528	CbGpPWpGaD
Silodosin—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000107	0.000528	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—GSTT1—esophageal cancer	0.000106	0.000525	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—WWOX—esophageal cancer	0.000106	0.000524	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—SST—esophageal cancer	0.000106	0.000522	CbGpPWpGaD
Silodosin—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000106	0.000521	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—CYP2A6—esophageal cancer	0.000105	0.000519	CbGpPWpGaD
Silodosin—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000105	0.00994	CcSEcCtD
Silodosin—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000105	0.000516	CbGpPWpGaD
Silodosin—Syncope—Capecitabine—esophageal cancer	0.000105	0.0099	CcSEcCtD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	0.000104	0.000514	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ADCYAP1—esophageal cancer	0.000103	0.000509	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—GHRL—esophageal cancer	0.000103	0.000509	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PDE4D—esophageal cancer	0.000103	0.000508	CbGpPWpGaD
Silodosin—Palpitations—Capecitabine—esophageal cancer	0.000103	0.00975	CcSEcCtD
Silodosin—ADRA1D—Signaling Pathways—PFN1—esophageal cancer	0.000103	0.000507	CbGpPWpGaD
Silodosin—Loss of consciousness—Capecitabine—esophageal cancer	0.000103	0.0097	CcSEcCtD
Silodosin—ADRA1B—Signaling Pathways—FKBP1A—esophageal cancer	0.000101	0.000499	CbGpPWpGaD
Silodosin—ADRA1D—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.000101	0.000499	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—ENO1—esophageal cancer	9.98e-05	0.000492	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PTGS1—esophageal cancer	9.98e-05	0.000492	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—ANXA1—esophageal cancer	9.96e-05	0.000491	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—WIF1—esophageal cancer	9.89e-05	0.000488	CbGpPWpGaD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	9.86e-05	0.00933	CcSEcCtD
Silodosin—UGT2B7—Metabolism—PSME2—esophageal cancer	9.83e-05	0.000484	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PSME1—esophageal cancer	9.83e-05	0.000484	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—GNG7—esophageal cancer	9.81e-05	0.000483	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—CXCL2—esophageal cancer	9.73e-05	0.000479	CbGpPWpGaD
Silodosin—Dry mouth—Capecitabine—esophageal cancer	9.71e-05	0.00919	CcSEcCtD
Silodosin—ADRA1B—GPCR downstream signaling—SST—esophageal cancer	9.69e-05	0.000477	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—CXCL2—esophageal cancer	9.52e-05	0.000469	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	9.51e-05	0.000468	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—WWOX—esophageal cancer	9.45e-05	0.000466	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—GHRL—esophageal cancer	9.44e-05	0.000465	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	9.4e-05	0.000463	CbGpPWpGaD
Silodosin—Shock—Capecitabine—esophageal cancer	9.37e-05	0.00886	CcSEcCtD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	9.36e-05	0.000461	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—BLVRB—esophageal cancer	9.34e-05	0.00046	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—SLC52A3—esophageal cancer	9.34e-05	0.00046	CbGpPWpGaD
Silodosin—Nervous system disorder—Capecitabine—esophageal cancer	9.34e-05	0.00883	CcSEcCtD
Silodosin—Tachycardia—Capecitabine—esophageal cancer	9.29e-05	0.00879	CcSEcCtD
Silodosin—Asthenia—Cisplatin—esophageal cancer	9.27e-05	0.00877	CcSEcCtD
Silodosin—Cardiac disorder—Methotrexate—esophageal cancer	9.26e-05	0.00876	CcSEcCtD
Silodosin—Skin disorder—Capecitabine—esophageal cancer	9.25e-05	0.00875	CcSEcCtD
Silodosin—ADRA1D—Signaling Pathways—ELMO1—esophageal cancer	9.24e-05	0.000456	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—EP300—esophageal cancer	9.21e-05	0.000454	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CSNK1A1—esophageal cancer	9.13e-05	0.00045	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	9.05e-05	0.000446	CbGpPWpGaD
Silodosin—Angiopathy—Methotrexate—esophageal cancer	9.05e-05	0.00856	CcSEcCtD
Silodosin—ADRA1B—Signaling by GPCR—ANXA1—esophageal cancer	9.04e-05	0.000446	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—AKAP13—esophageal cancer	9.03e-05	0.000445	CbGpPWpGaD
Silodosin—Immune system disorder—Methotrexate—esophageal cancer	9.01e-05	0.00853	CcSEcCtD
Silodosin—Mediastinal disorder—Methotrexate—esophageal cancer	8.99e-05	0.00851	CcSEcCtD
Silodosin—ADRA1A—Signaling Pathways—FKBP1A—esophageal cancer	8.99e-05	0.000443	CbGpPWpGaD
Silodosin—Hypotension—Capecitabine—esophageal cancer	8.9e-05	0.00842	CcSEcCtD
Silodosin—ADRA1A—GPCR downstream signaling—ANXA1—esophageal cancer	8.85e-05	0.000436	CbGpPWpGaD
Silodosin—Diarrhoea—Cisplatin—esophageal cancer	8.84e-05	0.00836	CcSEcCtD
Silodosin—ADRA1B—Signaling by GPCR—SST—esophageal cancer	8.8e-05	0.000434	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—WIF1—esophageal cancer	8.79e-05	0.000433	CbGpPWpGaD
Silodosin—Mental disorder—Methotrexate—esophageal cancer	8.74e-05	0.00827	CcSEcCtD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	8.66e-05	0.000427	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—CXCL2—esophageal cancer	8.64e-05	0.000426	CbGpPWpGaD
Silodosin—Insomnia—Capecitabine—esophageal cancer	8.61e-05	0.00815	CcSEcCtD
Silodosin—ADRA1A—GPCR downstream signaling—SST—esophageal cancer	8.61e-05	0.000424	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—GHRL—esophageal cancer	8.57e-05	0.000423	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PFN1—esophageal cancer	8.54e-05	0.000421	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—CYP1B1—esophageal cancer	8.48e-05	0.000418	CbGpPWpGaD
Silodosin—ADRA1B—G alpha (q) signalling events—PIK3CA—esophageal cancer	8.4e-05	0.000414	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—GHRL—esophageal cancer	8.39e-05	0.000413	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HIST1H2BM—esophageal cancer	8.34e-05	0.000411	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PDE4D—esophageal cancer	8.26e-05	0.000407	CbGpPWpGaD
Silodosin—Gastrointestinal disorder—Capecitabine—esophageal cancer	8.22e-05	0.00778	CcSEcCtD
Silodosin—Rash—Cisplatin—esophageal cancer	8.14e-05	0.0077	CcSEcCtD
Silodosin—Dermatitis—Cisplatin—esophageal cancer	8.14e-05	0.0077	CcSEcCtD
Silodosin—ADRA1A—Signaling Pathways—CSNK1A1—esophageal cancer	8.11e-05	0.0004	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	8.07e-05	0.000398	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—ANXA1—esophageal cancer	8.03e-05	0.000396	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—CYP19A1—esophageal cancer	7.97e-05	0.000393	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—SLC10A2—esophageal cancer	7.94e-05	0.000391	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CA1—esophageal cancer	7.94e-05	0.000391	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—GNG7—esophageal cancer	7.86e-05	0.000387	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	7.84e-05	0.000386	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—SST—esophageal cancer	7.82e-05	0.000385	CbGpPWpGaD
Silodosin—Gastrointestinal pain—Capecitabine—esophageal cancer	7.79e-05	0.00737	CcSEcCtD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	7.69e-05	0.000379	CbGpPWpGaD
Silodosin—Nausea—Cisplatin—esophageal cancer	7.67e-05	0.00726	CcSEcCtD
Silodosin—ADRA1B—Signaling Pathways—ELMO1—esophageal cancer	7.67e-05	0.000378	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	7.66e-05	0.000378	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—GHRL—esophageal cancer	7.62e-05	0.000375	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PFN1—esophageal cancer	7.59e-05	0.000374	CbGpPWpGaD
Silodosin—Urticaria—Capecitabine—esophageal cancer	7.56e-05	0.00716	CcSEcCtD
Silodosin—Abdominal pain—Capecitabine—esophageal cancer	7.53e-05	0.00712	CcSEcCtD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	7.51e-05	0.00037	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—AKAP13—esophageal cancer	7.5e-05	0.00037	CbGpPWpGaD
Silodosin—ADRA1A—G alpha (q) signalling events—PIK3CA—esophageal cancer	7.46e-05	0.000368	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—XIAP—esophageal cancer	7.37e-05	0.000363	CbGpPWpGaD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	7.34e-05	0.00695	CcSEcCtD
Silodosin—UGT2B7—Metabolism—HMOX1—esophageal cancer	7.28e-05	0.000359	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CA2—esophageal cancer	7.26e-05	0.000358	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—ABCB1—esophageal cancer	6.98e-05	0.000344	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CTNNA1—esophageal cancer	6.96e-05	0.000343	CbGpPWpGaD
Silodosin—Nervous system disorder—Methotrexate—esophageal cancer	6.95e-05	0.00658	CcSEcCtD
Silodosin—ADRA1D—Signaling Pathways—CXCL2—esophageal cancer	6.92e-05	0.000341	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	6.92e-05	0.000341	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HIST1H2BM—esophageal cancer	6.92e-05	0.000341	CbGpPWpGaD
Silodosin—Skin disorder—Methotrexate—esophageal cancer	6.89e-05	0.00651	CcSEcCtD
Silodosin—ADRA1B—Signaling Pathways—PDE4D—esophageal cancer	6.86e-05	0.000338	CbGpPWpGaD
Silodosin—Asthenia—Capecitabine—esophageal cancer	6.83e-05	0.00646	CcSEcCtD
Silodosin—ADRA1A—Signaling Pathways—ELMO1—esophageal cancer	6.81e-05	0.000336	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—PIK3CA—esophageal cancer	6.81e-05	0.000336	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PLCE1—esophageal cancer	6.75e-05	0.000333	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ADH7—esophageal cancer	6.75e-05	0.000333	CbGpPWpGaD
Silodosin—Pruritus—Capecitabine—esophageal cancer	6.74e-05	0.00637	CcSEcCtD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	6.7e-05	0.00033	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	6.67e-05	0.000329	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—AKAP13—esophageal cancer	6.66e-05	0.000328	CbGpPWpGaD
Silodosin—Hypotension—Methotrexate—esophageal cancer	6.62e-05	0.00627	CcSEcCtD
Silodosin—ADRA1B—Signaling Pathways—GNG7—esophageal cancer	6.52e-05	0.000321	CbGpPWpGaD
Silodosin—Diarrhoea—Capecitabine—esophageal cancer	6.52e-05	0.00616	CcSEcCtD
Silodosin—ADRA1D—Signaling Pathways—PSME2—esophageal cancer	6.47e-05	0.000319	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PSME1—esophageal cancer	6.47e-05	0.000319	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—ANXA1—esophageal cancer	6.44e-05	0.000317	CbGpPWpGaD
Silodosin—Insomnia—Methotrexate—esophageal cancer	6.41e-05	0.00606	CcSEcCtD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	6.37e-05	0.000314	CbGpPWpGaD
Silodosin—Dizziness—Capecitabine—esophageal cancer	6.3e-05	0.00596	CcSEcCtD
Silodosin—ADRA1D—Signaling Pathways—SST—esophageal cancer	6.26e-05	0.000309	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HIST1H2BM—esophageal cancer	6.15e-05	0.000303	CbGpPWpGaD
Silodosin—Gastrointestinal disorder—Methotrexate—esophageal cancer	6.12e-05	0.00579	CcSEcCtD
Silodosin—ADRA1B—Signaling Pathways—XIAP—esophageal cancer	6.11e-05	0.000301	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NOTCH3—esophageal cancer	6.1e-05	0.000301	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—GHRL—esophageal cancer	6.1e-05	0.000301	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PDE4D—esophageal cancer	6.09e-05	0.0003	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—FBXW7—esophageal cancer	6e-05	0.000296	CbGpPWpGaD
Silodosin—Rash—Capecitabine—esophageal cancer	6e-05	0.00568	CcSEcCtD
Silodosin—Dermatitis—Capecitabine—esophageal cancer	6e-05	0.00567	CcSEcCtD
Silodosin—Headache—Capecitabine—esophageal cancer	5.97e-05	0.00564	CcSEcCtD
Silodosin—ABCB1—Metabolism—ADH1B—esophageal cancer	5.92e-05	0.000292	CbGpPWpGaD
Silodosin—Gastrointestinal pain—Methotrexate—esophageal cancer	5.8e-05	0.00548	CcSEcCtD
Silodosin—ADRA1A—Signaling Pathways—GNG7—esophageal cancer	5.79e-05	0.000286	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	5.79e-05	0.000285	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CTNNA1—esophageal cancer	5.78e-05	0.000285	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SLC52A3—esophageal cancer	5.75e-05	0.000284	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—BLVRB—esophageal cancer	5.75e-05	0.000284	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CXCL2—esophageal cancer	5.75e-05	0.000283	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—TYMP—esophageal cancer	5.66e-05	0.000279	CbGpPWpGaD
Silodosin—Nausea—Capecitabine—esophageal cancer	5.66e-05	0.00535	CcSEcCtD
Silodosin—Urticaria—Methotrexate—esophageal cancer	5.63e-05	0.00533	CcSEcCtD
Silodosin—Abdominal pain—Methotrexate—esophageal cancer	5.6e-05	0.0053	CcSEcCtD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	5.55e-05	0.000274	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CYP26A1—esophageal cancer	5.51e-05	0.000271	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NOTCH2—esophageal cancer	5.47e-05	0.00027	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	5.43e-05	0.000268	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—XIAP—esophageal cancer	5.43e-05	0.000268	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PSME1—esophageal cancer	5.37e-05	0.000265	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PSME2—esophageal cancer	5.37e-05	0.000265	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ALOX15—esophageal cancer	5.36e-05	0.000264	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ANXA1—esophageal cancer	5.34e-05	0.000263	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—SST—esophageal cancer	5.2e-05	0.000256	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CTNNA1—esophageal cancer	5.13e-05	0.000253	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GSTO1—esophageal cancer	5.12e-05	0.000252	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—TPI1—esophageal cancer	5.12e-05	0.000252	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CXCL2—esophageal cancer	5.11e-05	0.000252	CbGpPWpGaD
Silodosin—Asthenia—Methotrexate—esophageal cancer	5.09e-05	0.00481	CcSEcCtD
Silodosin—ADRA1B—Signaling Pathways—NOTCH3—esophageal cancer	5.07e-05	0.00025	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—GHRL—esophageal cancer	5.07e-05	0.00025	CbGpPWpGaD
Silodosin—Pruritus—Methotrexate—esophageal cancer	5.02e-05	0.00474	CcSEcCtD
Silodosin—ADRA1B—Signaling Pathways—FBXW7—esophageal cancer	4.98e-05	0.000246	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ALDOB—esophageal cancer	4.91e-05	0.000242	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CA1—esophageal cancer	4.89e-05	0.000241	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SLC10A2—esophageal cancer	4.89e-05	0.000241	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TGFBR2—esophageal cancer	4.86e-05	0.000239	CbGpPWpGaD
Silodosin—Diarrhoea—Methotrexate—esophageal cancer	4.85e-05	0.00459	CcSEcCtD
Silodosin—ADRA1A—Signaling Pathways—PSME1—esophageal cancer	4.77e-05	0.000235	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PSME2—esophageal cancer	4.77e-05	0.000235	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ANXA1—esophageal cancer	4.75e-05	0.000234	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GAPDH—esophageal cancer	4.72e-05	0.000233	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	4.71e-05	0.000232	CbGpPWpGaD
Silodosin—Dizziness—Methotrexate—esophageal cancer	4.69e-05	0.00443	CcSEcCtD
Silodosin—ABCB1—Metabolism—CRABP1—esophageal cancer	4.68e-05	0.000231	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—CREBBP—esophageal cancer	4.67e-05	0.00023	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SST—esophageal cancer	4.62e-05	0.000228	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—SMAD4—esophageal cancer	4.6e-05	0.000227	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	4.56e-05	0.000225	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NOTCH2—esophageal cancer	4.54e-05	0.000224	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NOTCH3—esophageal cancer	4.5e-05	0.000222	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—GHRL—esophageal cancer	4.5e-05	0.000222	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CA2—esophageal cancer	4.48e-05	0.000221	CbGpPWpGaD
Silodosin—Rash—Methotrexate—esophageal cancer	4.47e-05	0.00423	CcSEcCtD
Silodosin—Dermatitis—Methotrexate—esophageal cancer	4.47e-05	0.00422	CcSEcCtD
Silodosin—ABCB1—Metabolism—GNG7—esophageal cancer	4.45e-05	0.000219	CbGpPWpGaD
Silodosin—Headache—Methotrexate—esophageal cancer	4.44e-05	0.0042	CcSEcCtD
Silodosin—ADRA1A—Signaling Pathways—FBXW7—esophageal cancer	4.43e-05	0.000218	CbGpPWpGaD
Silodosin—Nausea—Methotrexate—esophageal cancer	4.21e-05	0.00398	CcSEcCtD
Silodosin—UGT2B7—Metabolism—NOS3—esophageal cancer	4.18e-05	0.000206	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ALDH2—esophageal cancer	4.17e-05	0.000206	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PLCE1—esophageal cancer	4.16e-05	0.000205	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ADH7—esophageal cancer	4.16e-05	0.000205	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NOTCH2—esophageal cancer	4.04e-05	0.000199	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TGFBR2—esophageal cancer	4.03e-05	0.000199	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GSTT1—esophageal cancer	3.97e-05	0.000196	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CYP2A6—esophageal cancer	3.92e-05	0.000193	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PTGS2—esophageal cancer	3.82e-05	0.000188	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—SMAD4—esophageal cancer	3.81e-05	0.000188	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HIF1A—esophageal cancer	3.76e-05	0.000185	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PTGS1—esophageal cancer	3.72e-05	0.000183	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ENO1—esophageal cancer	3.72e-05	0.000183	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.72e-05	0.000183	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PSME2—esophageal cancer	3.66e-05	0.000181	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PSME1—esophageal cancer	3.66e-05	0.000181	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ADH1B—esophageal cancer	3.65e-05	0.00018	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—KDR—esophageal cancer	3.6e-05	0.000177	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TGFBR2—esophageal cancer	3.58e-05	0.000176	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—TYMP—esophageal cancer	3.49e-05	0.000172	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CYP26A1—esophageal cancer	3.39e-05	0.000167	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—SMAD4—esophageal cancer	3.39e-05	0.000167	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NOTCH1—esophageal cancer	3.39e-05	0.000167	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ALOX15—esophageal cancer	3.31e-05	0.000163	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—EP300—esophageal cancer	3.18e-05	0.000157	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CYP1B1—esophageal cancer	3.16e-05	0.000156	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—TPI1—esophageal cancer	3.15e-05	0.000155	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GSTO1—esophageal cancer	3.15e-05	0.000155	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HIF1A—esophageal cancer	3.12e-05	0.000154	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CREBBP—esophageal cancer	3.07e-05	0.000151	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ALDOB—esophageal cancer	3.02e-05	0.000149	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—EGFR—esophageal cancer	3.02e-05	0.000149	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—KDR—esophageal cancer	2.99e-05	0.000147	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CYP19A1—esophageal cancer	2.97e-05	0.000146	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GAPDH—esophageal cancer	2.91e-05	0.000143	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—PIK3CA—esophageal cancer	2.89e-05	0.000142	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CRABP1—esophageal cancer	2.88e-05	0.000142	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NOTCH1—esophageal cancer	2.81e-05	0.000139	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HIF1A—esophageal cancer	2.77e-05	0.000137	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NOS3—esophageal cancer	2.75e-05	0.000136	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GNG7—esophageal cancer	2.74e-05	0.000135	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—HMOX1—esophageal cancer	2.71e-05	0.000134	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—KDR—esophageal cancer	2.65e-05	0.000131	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—PIK3CA—esophageal cancer	2.62e-05	0.000129	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—ERBB2—esophageal cancer	2.57e-05	0.000127	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ALDH2—esophageal cancer	2.57e-05	0.000127	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CREBBP—esophageal cancer	2.55e-05	0.000126	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—EGFR—esophageal cancer	2.51e-05	0.000123	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NOTCH1—esophageal cancer	2.5e-05	0.000123	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GSTT1—esophageal cancer	2.44e-05	0.00012	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CYP2A6—esophageal cancer	2.42e-05	0.000119	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—PIK3CA—esophageal cancer	2.39e-05	0.000118	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PIK3CA—esophageal cancer	2.35e-05	0.000116	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ENO1—esophageal cancer	2.29e-05	0.000113	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PTGS1—esophageal cancer	2.29e-05	0.000113	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NOS3—esophageal cancer	2.28e-05	0.000112	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CCND1—esophageal cancer	2.27e-05	0.000112	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CREBBP—esophageal cancer	2.26e-05	0.000112	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PSME2—esophageal cancer	2.26e-05	0.000111	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PSME1—esophageal cancer	2.26e-05	0.000111	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—EGFR—esophageal cancer	2.23e-05	0.00011	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CDKN1A—esophageal cancer	2.2e-05	0.000108	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—PIK3CA—esophageal cancer	2.17e-05	0.000107	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ERBB2—esophageal cancer	2.14e-05	0.000105	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—PIK3CA—esophageal cancer	2.13e-05	0.000105	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—EP300—esophageal cancer	2.09e-05	0.000103	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NOS3—esophageal cancer	2.03e-05	9.99e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.95e-05	9.6e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PIK3CA—esophageal cancer	1.93e-05	9.52e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ERBB2—esophageal cancer	1.9e-05	9.35e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CCND1—esophageal cancer	1.89e-05	9.3e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.83e-05	9.03e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CDKN1A—esophageal cancer	1.82e-05	8.99e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MYC—esophageal cancer	1.82e-05	8.98e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—EGFR—esophageal cancer	1.78e-05	8.79e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—CREBBP—esophageal cancer	1.74e-05	8.58e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—EP300—esophageal cancer	1.74e-05	8.56e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CCND1—esophageal cancer	1.68e-05	8.26e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.67e-05	8.24e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CDKN1A—esophageal cancer	1.62e-05	7.99e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.6e-05	7.91e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—NOS3—esophageal cancer	1.56e-05	7.68e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PIK3CA—esophageal cancer	1.55e-05	7.63e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—EP300—esophageal cancer	1.54e-05	7.6e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MYC—esophageal cancer	1.51e-05	7.46e-05	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TP53—esophageal cancer	1.5e-05	7.38e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—EGFR—esophageal cancer	1.48e-05	7.29e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PTGS2—esophageal cancer	1.43e-05	7.02e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MYC—esophageal cancer	1.34e-05	6.62e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—EGFR—esophageal cancer	1.31e-05	6.48e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PIK3CA—esophageal cancer	1.28e-05	6.33e-05	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TP53—esophageal cancer	1.24e-05	6.12e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—EP300—esophageal cancer	1.19e-05	5.84e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PIK3CA—esophageal cancer	1.14e-05	5.62e-05	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TP53—esophageal cancer	1.1e-05	5.44e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.07e-05	5.28e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—NOS3—esophageal cancer	9.6e-06	4.73e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PTGS2—esophageal cancer	8.78e-06	4.33e-05	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PIK3CA—esophageal cancer	8.77e-06	4.32e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—EP300—esophageal cancer	7.3e-06	3.6e-05	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PIK3CA—esophageal cancer	5.4e-06	2.66e-05	CbGpPWpGaD
